Author

Luke J. Bonanni

New York UniversityORCID 0000-0002-1730-0486Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Research Focus:gene regulatory network inference· 1 Organism:human· 1 Assay:proteomics· 1 Approach:statistical model· 1

Frequent Co-Authors

Adler Guerrero· 1 shared Albert Jiang· 1 shared Alex Donovan· 1 shared Andrea H. BrandiD· 1 shared Andrea Leonard· 1 shared Anuva Ghosh· 1 shared C. Theresa VincentiD· 1 shared Claire Kim· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Adler Guerrero

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Purinergic signaling promotes gliomagenesis through nuclear calcium transients

Shuai Wang, Jenna Richter, Claire Kim, Rebecca Ronnen, Julia Cai, Yunfei Song, Sara Haddock, Mark B. Stoessel, Hannah Dada, Suzanne Gross, Adler Guerrero, Theodoris Karnavas, Gabriele Stephan, Greg Belizaire, Luke J. Bonanni, , Dimitris G. Placantonakis

This study identifies purinergic signaling via P2RY1 receptors and nuclear calcium transients as a driver of glioblastoma tumorigenesis, with therapeutic potential through P2RY1 inhibition.

bioRxiv · May 15, 2026 · PreprintCancer Biology